-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Zinc is a trace element that plays an important role in stimulating innate and acquired immunity
.
The role of zinc in critically ill patients with COVID-19 is not yet clear
Immune to COVID-19
Recently, a research article published in Critical Care, an authoritative journal in the field of critical care medicine, aims to evaluate the effectiveness and safety of zinc sulfate as an adjuvant treatment for critically ill patients with COVID-19
.
Researchers conducted a retrospective evaluation of zinc use in patients with COVID-19 who were admitted to the intensive care unit (ICU) in two tertiary hospitals in Saudi Arabia from March 1, 2020 to March 31, 2021 and were aged ≥18 years.
.
After matching propensity scores based on selected criteria (1:1 ratio), the researchers assessed the association between zinc used as an adjuvant treatment and 30-day mortality
A total of 164 patients were enrolled in the study, and 82 patients were treated with zinc
.
Patients who received zinc sulfate as adjuvant therapy had a lower 30-day mortality rate (HR 0.
It can be seen that the use of zinc sulfate as a supplementary treatment for critically ill patients with COVID-19 may improve survival
.
In addition, zinc supplementation may have a protective effect on the kidneys
Using zinc sulfate as a supplementary treatment for critically ill patients with COVID-19 may improve survival
Original source:
Khalid Al Sulaiman.
Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study in this message